Integrated Advisors Network LLC Buys Shares of 3,928 Addus HomeCare Co. (NASDAQ:ADUS)

Integrated Advisors Network LLC bought a new stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 3,928 shares of the company’s stock, valued at approximately $523,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. grew its position in Addus HomeCare by 3.2% in the 4th quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock valued at $116,753,000 after acquiring an additional 38,876 shares during the last quarter. BNP Paribas Financial Markets increased its stake in Addus HomeCare by 20.3% in the 1st quarter. BNP Paribas Financial Markets now owns 11,854 shares of the company’s stock worth $1,225,000 after buying an additional 2,000 shares during the period. Quantbot Technologies LP bought a new stake in Addus HomeCare during the 1st quarter valued at about $715,000. Empowered Funds LLC boosted its position in Addus HomeCare by 9.8% in the 1st quarter. Empowered Funds LLC now owns 6,890 shares of the company’s stock valued at $712,000 after buying an additional 615 shares during the period. Finally, TimesSquare Capital Management LLC grew its stake in Addus HomeCare by 9.8% in the 1st quarter. TimesSquare Capital Management LLC now owns 289,998 shares of the company’s stock worth $29,968,000 after acquiring an additional 25,910 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares of the company’s stock, valued at $429,165. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 22,917 shares of company stock worth $3,050,082 in the last ninety days. 4.60% of the stock is owned by insiders.

Analyst Ratings Changes

Several analysts have recently weighed in on ADUS shares. TD Cowen lifted their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. StockNews.com cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 7th. KeyCorp began coverage on Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price target on the stock. Oppenheimer upped their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Finally, Stephens reissued an “overweight” rating and set a $138.00 target price on shares of Addus HomeCare in a research report on Tuesday, August 6th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $131.38.

Addus HomeCare Stock Performance

ADUS stock opened at $124.42 on Friday. Addus HomeCare Co. has a one year low of $78.35 and a one year high of $136.12. The firm has a market cap of $2.25 billion, a price-to-earnings ratio of 30.87, a PEG ratio of 2.33 and a beta of 1.04. The firm has a 50-day simple moving average of $130.32 and a two-hundred day simple moving average of $119.87.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, August 5th. The company reported $1.35 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.14. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The company had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. During the same quarter in the prior year, the company posted $0.94 earnings per share. Addus HomeCare’s revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, equities analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.